By Ome Ogbru, PharmD, CEO and founder, AINGENS
LinkedIn: Ome Ogbru, PharmD
LinkedIn: AINGENS
Artificial intelligence is rapidly becoming embedded in healthcare and scientific communication, but the industry is approaching a critical inflection point. The challenge is no longer whether large language models can generate convincing clinical or scientific content. It is whether healthcare organizations can reliably govern these systems and trust the information they produce.
A recent analysis of 7,251 JAMA Network Open articles using a commercial AI-detection tool found that the proportion of publications with detectable AI-generated text increased from 0.0% in January 2022 to approximately 11% by March 2025. This signals how quickly generative AI is entering medical literature and publishing workflows. At the same time, recent evaluations of AI-generated medical advice across common patient scenarios found that, among incorrect responses, approximately 20% were judged potentially harmful if followed. A multi-model clinical study using adversarial prompts with fabricated clinical details reported hallucination rates from 50% to 82%, even when prompt-based mitigation techniques were applied.
These findings reveal a growing reliability problem inside healthcare and scientific workflows. In environments where decisions influence patient care, clinical strategy, regulatory submissions, and scientific credibility, inaccurate AI-generated information is not simply a technical issue. It is a trust and governance issue.
How ‘Hallucinations’ Become Misinformation
The phrase “AI hallucination” is often used to describe fabricated outputs, but in healthcare and clinical research, “misinformation” may be a more accurate framing. These systems are capable of generating incorrect references, unsupported claims, misleading summaries, and invented clinical details while presenting them with fluency and confidence.
This creates a unique challenge in scientific and medical environments because errors often appear plausible enough to pass initial review. AI systems do not inherently distinguish between verified evidence and statistically probable language patterns. Their objective is coherence, not factual accountability.
The problem becomes more pronounced in high-stakes clinical contexts involving dense medical terminology, large evidence sets, nuanced interpretation, and citation-heavy workflows. When users provide incomplete information, misleading prompts, or poorly structured data, models can elaborate on false details rather than acknowledge uncertainty.
The recent multi-model assurance analysis on adversarial hallucinations demonstrated how vulnerable these systems remain when exposed to fabricated clinical inputs. Even with specialized prompting designed to reduce misinformation, hallucination rates remained significant across all tested models. This suggests that prompt engineering alone cannot solve the problem.
As AI-generated content becomes more common in medical literature, publishing, and decision support, healthcare organizations must confront a difficult reality: plausibility is not the same as reliability.
The Workflow Problem Behind AI Misinformation. The Human Verification Gap
Many discussions about AI safety focus almost exclusively on the underlying model architecture and training data. In practice, however, misinformation risk is heavily influenced by workflow design and user behavior.
Large language models are often deployed into environments that were not built for probabilistic systems. Users upload large collections of unstructured documents, provide vague prompts, and expect publication-ready outputs in a single interaction. In many cases, the AI is treated as an answer engine instead of a collaborative drafting and synthesis tool requiring oversight.
This creates conditions where misinformation can spread rapidly across research summaries, medical affairs materials, presentations, and internal documentation.
Human behavior also plays a major role. If users fail to verify citations, review supporting evidence, or understand the limitations of the systems they are using, inaccurate outputs are far more likely to enter downstream workflows. The issue is not simply that AI systems can be wrong. It is that organizations may unknowingly operationalize those errors at scale.
In healthcare, that creates both ethical and operational risks. Studies now show that a growing number of individuals are using AI systems for health-related guidance, and some report delaying or avoiding professional medical care because of AI-generated information. As adoption accelerates, the consequences of misinformation extend beyond publishing concerns into patient safety and clinical decision-making.
Moving Toward Evidence-Grounded AI. Constrain Models to Governed Evidence
Healthcare organizations are increasingly shifting toward evidence-grounded workflows that constrain AI systems to verifiable sources rather than relying primarily on generalized training data. In these environments, AI outputs are tied directly to peer-reviewed literature, approved internal documents, curated evidence libraries, or curated databases.
This shift allows organizations to operationalize traceability and auditability inside clinical workflows. Instead of asking users to trust the model, the workflow is designed to make evidence visible and verifiable.
Effective implementation starts with narrowing the scope of what AI is asked to do. Complex scientific tasks should be broken into smaller stages with focused inputs, iterative review, and clear checkpoints for validation. Organizations are also beginning to prioritize systems that surface supporting references alongside outputs, enabling users to trace claims back to source material rather than reverse-engineering the reasoning afterward.
Another important safeguard is explicit uncertainty handling. AI systems should acknowledge when evidence is incomplete or unavailable instead of confidently generating speculative answers to satisfy a prompt. Equally important is maintaining human accountability throughout the process. Clinical and scientific professionals must remain responsible for validating outputs before information influences care decisions, publications, or regulatory submissions.
These implementation shifts reflect a broader recognition that healthcare does not operate in an environment where “mostly accurate” is sufficient.
Trust Will Define the Next Phase of AI Adoption
The healthcare industry is entering a new phase of AI adoption where trust matters more than novelty. The organizations that succeed will not necessarily be the ones using the most advanced models. They will be the ones that build workflows capable of making AI outputs transparent, auditable, and aligned with evidence.
As AI-generated content becomes increasingly common across medical research and publishing, maintaining scientific integrity will depend less on model capability alone and more on how these systems are governed and implemented.
The future of AI in healthcare will not be defined by systems that seek to replace expertise, but by systems that strengthen human expertise while preserving accountability, traceability, and trust.